N/A
N=66
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine
Community Acquired Pneumonia
Bottom Line
View on ClinicalTrials.gov: NCT01875731 ↗Enrolled (actual)
66
Serious AEs
0.0%
Results posted
May 2015
Primary outcome: Primary: Use of Antibiotics in Each Group — 9; 21 participants — p=0.01
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- BPS (Behavioral); Guideline (Behavioral)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- Hospital General de Niños Pedro de Elizalde
- Primary completion
- May 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Use of Antibiotics in Each Group |
9; 21 | 0.01 sig |
| SECONDARY Treatment Failure in Each Group |
3; 4 | 0.71 |
Summary
The aim of this study is to test if BPS (Bacterial Pneumonia Score) guided antibiotic use in children with non severe community acquired pneumonia (CAP) and pneumoccocal vaccine will reduce antibiotic use as compared to standard care practice (current guidelines for CAP).
Eligibility Criteria
Inclusion Criteria
- Children aged 3-60 months assisted as outpatients for non severe community acquired pneumonia and pneumoccocal vaccine and complete immunisation with pneumoccocal vaccine.
Exclusion Criteria
- Wheezing
- Severe pneumonia
- Pulmonary or cardiovascular chronic disease
- Antibiotic use in the previous two weeks
- Hospitalization for any reason in the previous two weeks
Data sourced from ClinicalTrials.gov (NCT01875731). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.